Grapheal develops wearable and disposable biosensors enabling continuous monitoring and on-site diagnosis. It empowers caregivers with an improved and individualized assessment tool for precision medicine.
BRINGING THE FUTURE OF DATA-DRIVEN WOUND CARE
More than 6.5 million persons are suffering from chronic wounds in the United States. The cost and incidence of chronic wounds is increasing, due to the aging population, and the increased prevalence of diabetes.
New treatments for chronic wounds have led to improvements in wound management but wound monitoring tools and methodologies have not kept pace with this progress. Wound assessment is complex and requires a range of clinical skills and knowledge.
That is why wound care at home is expensive and often innefficient given that care providers simply do not have the necessary tools to accurately track wound healing over time.
415 million people suffer from diabetes worldwide
25% will develop a chronic wound (Diabetic Foot Ulcer)
500,000 amputations each year are caused by DFU complications
The estimated US healthcare cost of DFU is $13 billion/year
REMOTE MONITORING OF HEALING
Grapheal presents an electronic wound patch that continuously measures and stores wound biometric parameters, and communicates them to a medical cloud via a smartphone app.
Thus, doctors and nurses can monitor the wound healing evolution remotely and be alerted of any early-stage infection, and prevent complications. Grapheal patches will make any bandage smart & connected.